Su Ding-Feng, Miao Chao-Yu
Department of Pharmacology, Second Military Medical University, Shanghai 200433, China.
Trends Pharmacol Sci. 2005 Aug;26(8):388-90. doi: 10.1016/j.tips.2005.06.003.
The main aims of the treatment of hypertension are to prevent end-organ damage (EOD) and to avoid consequent lethal complications associated with hypertension. Blood pressure level is a well-known determinant of EOD. However, recent studies suggest that blood pressure variability (BPV) is as important as blood pressure level in determining EOD. The reduction of BPV is an important contributory factor of the organ protection provided by some antihypertensive drugs. Thus, reduction of BPV might represent a new strategy for the treatment of hypertension.
高血压治疗的主要目标是预防靶器官损害(EOD)并避免与高血压相关的致命并发症。血压水平是众所周知的靶器官损害的决定因素。然而,最近的研究表明,血压变异性(BPV)在决定靶器官损害方面与血压水平同样重要。降低BPV是一些抗高血压药物提供器官保护的重要促成因素。因此,降低BPV可能代表一种治疗高血压的新策略。